Literature DB >> 24449084

Effect of Abnormal Savda Munziq on hypertrophic scar formation in a rabbit ear model.

Hu-jun Wang1, Wei-cheng Gao, Shao-lin Ma.   

Abstract

OBJECTIVE: To investigate whether administrating Abnormal Savda Munziq (ASMq), a traditional Uighur herbal preparation used for the prevention or treatment of diseases, affects hypertrophic scar (HTS) formation by using an established rabbit ear model.
METHODS: The HTS rabbit model was created by circular fullthickness skin excisions on both ears of rabbits. Twenty rabbits were randomized into four groups, with 5 rabbits and 60 wounds in each group. Group A was the control group, treated with normal saline daily. Groups B, C, and D were the treatment groups at three different doses of ASMq (400, 800, and 1200 mg/kg body weight, respectively, daily, by gastrogavage). Twenty wounds were randomly chosen from each group on the 40th day after treatment and specimen were examined. Scar elevation index (SEI) was analyzed with histological assessment, and ultrastructure analysis was analyzed with a transmission electron microscopy.
RESULTS: Groups B, C, and D demonstrated significant reductions in SEI as compared with the control group at 35.9% (P=0.0212), 48.2% (P=0.0108), and 52.7% (P=0.0103), respectively in a dose-response manner. SEI was lowered in Group D compared with Group B with a significant difference (P=0.015). However, there were no significant differences between Groups B and C, or between Groups C and D. Histological analysis showed that highdose ASMq (1200 mg/kg) could enhance the softening of HTS of rabbit ears and increase the compliance as shown in general. Ultrastructure analysis showed that with increased ASMq dose, the fibroblasts, pro-collagen, collagen, endoplasmic reticulum and ribosomes were reduced gradually.
CONCLUSIONS: Orally administered ASMq significantly reduces the severity of HTS in the rabbit ear model. The findings of this study may have clinical implications on the management of human HTS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24449084     DOI: 10.1007/s11655-014-1622-4

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  21 in total

1.  Protective effects of Munziq and Mushil of abnormal Savda to mitochondrial oxidative damage.

Authors:  Abdiryim Yusup; Halmurat Upur; Anwar Umar; Nicholas Moore
Journal:  Fundam Clin Pharmacol       Date:  2004-08       Impact factor: 2.748

2.  HMG-CoA reductase inhibitors (statins) reduce hypertrophic scar formation in a rabbit ear wounding model.

Authors:  Jason H Ko; Peter S Kim; Yanan Zhao; Seok Jong Hong; Thomas A Mustoe
Journal:  Plast Reconstr Surg       Date:  2012-02       Impact factor: 4.730

Review 3.  Cellular and molecular pathology of HTS: basis for treatment.

Authors:  Alexis Armour; Paul G Scott; Edward E Tredget
Journal:  Wound Repair Regen       Date:  2007 Sep-Oct       Impact factor: 3.617

4.  Normal skin and hypertrophic scar fibroblasts differentially regulate collagen and fibronectin expression as well as mitochondrial membrane potential in response to basic fibroblast growth factor.

Authors:  Rui Song; Hui-Ning Bian; Wen Lai; Hua-De Chen; Ke-Seng Zhao
Journal:  Braz J Med Biol Res       Date:  2011-04-01       Impact factor: 2.590

5.  Asiaticoside suppresses collagen expression and TGF-β/Smad signaling through inducing Smad7 and inhibiting TGF-βRI and TGF-βRII in keloid fibroblasts.

Authors:  Bing Tang; Bin Zhu; Yueying Liang; Liangkuan Bi; Zhicheng Hu; Bin Chen; Kai Zhang; Jiayuan Zhu
Journal:  Arch Dermatol Res       Date:  2011-01-15       Impact factor: 3.017

6.  Effects of asiaticoside on the expression of Smad protein by normal skin fibroblasts and hypertrophic scar fibroblasts.

Authors:  S H Qi; J-L Xie; S Pan; Y-B Xu; T-Z Li; J-M Tang; X-S Liu; B Shu; P Liu
Journal:  Clin Exp Dermatol       Date:  2008-01-14       Impact factor: 3.470

7.  Suppression of cell proliferation and collagen production in cultured human hypertrophic scar fibroblasts by Sp1 decoy oligodeoxynucleotide.

Authors:  Chenliang Deng; Jianghong Zheng; Weidong Wan; Shixin Zhang; Zhi Ding; Guangyu Mao; Songlin Yang
Journal:  Mol Med Rep       Date:  2013-01-18       Impact factor: 2.952

8.  The molecular mechanism of hypertrophic scar.

Authors:  Zhensen Zhu; Jie Ding; Heather A Shankowsky; Edward E Tredget
Journal:  J Cell Commun Signal       Date:  2013-03-18       Impact factor: 5.782

9.  Hyperactivity of fibroblasts and functional regression of endothelial cells contribute to microvessel occlusion in hypertrophic scarring.

Authors:  Wang Xi-Qiao; Liu Ying-Kai; Qing Chun; Lu Shu-Liang
Journal:  Microvasc Res       Date:  2008-09-18       Impact factor: 3.514

10.  Abnormal Savda Munziq, an Herbal Preparation of Traditional Uighur Medicine, May Prevent 1,2-dimethylhydrazine-Induced Rat Colon Carcinogenesis.

Authors:  Abdiryim Yusup; Halmurat Upur; Anwar Umar; Benedicte Berke; Dilxat Yimit; Jaya Conser Lapham; Nicholas Moore; Pierrette Cassand
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-16       Impact factor: 2.629

View more
  2 in total

Review 1.  A Systematic Review Comparing Animal and Human Scarring Models.

Authors:  Riyam Mistry; Mark Veres; Fadi Issa
Journal:  Front Surg       Date:  2022-04-22

2.  Differential integrative omic analysis for mechanism insights and biomarker discovery of abnormal Savda syndrome and its unique Munziq prescription.

Authors:  Xia Guo; Iskandar Bakri; Abulizi Abudula; Kalbinur Arken; Mahmut Mijit; Batur Mamtimin; Halmurat Upur
Journal:  Sci Rep       Date:  2016-06-14       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.